Phase 2a Study of Baxdrostat in Primary Aldosteronism
Year: 2025
Type: article
Study design: Clinical Trial
Source: New England Journal of Medicine
DOI: 10.1056/nejmc2508629
Institutions: University of Michigan, Harvard University, Mayo Clinic, Cedars-Sinai Medical Center, The University of Texas Southwestern Medical Center, Johns Hopkins University, Northwestern University, The Ohio State University Wexner Medical Center, University of California, San Francisco, AstraZeneca (United States), AstraZeneca (Sweden), Queen Mary University of London
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: AstraZeneca
OpenAlex ID: W4412376043
